MECHANISM OF ACTION
TYVASO IS A DIRECT-TO-LUNG, INHALED PROSTACYCLIN
TYVASO promotes direct vasodilation of pulmonary and systemic arterial vascular beds and inhibition of platelet aggregation.1
TREAT AT THE SITE OF DISEASE
Direct-to-lung delivery results in higher concentrations in the pulmonary arterial vasculature, which may selectively enhance blood flow for better ventilation and perfusion matching with less off-target exposure.2
TYVASO INHALATION SYSTEM
Find additional resources and information on how TYVASO is used for direct-to-lung delivery of inhaled prostacyclin.